Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Nafloxin Cooper


To avoid
As a precautionary measure

Not recommended
Use with caution
Nafloxin Cooper :
Type Medicine Rejected
Originator Ciloxan
Agent Mapico
Distributor Mapico
Laboratory Cooper Pharmaceuticals
Manufacturer Cooper SA Pharmaceuticals
Manufacturing Type G
Origin Greece
ATC S01AE03

Your comment will appear shortly after approval

Nafloxin Cooper :

Revision Date : 01/06/2013


Effect Frequency
Abnormal sensation in eye Common
Corneal infiltrates Uncommon
Dermatitis exfoliative Very rare
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Epidermolysis Very rare
Eye allergy Uncommon
Eye irritation Common
Eye pruritus Common
Eyelid margin crusting Common
Eyelid oedema Uncommon
Hypersensitivity Very rare
Keratitis Uncommon
Keratopathy Uncommon
Lacrimation increased (Epiphora) Uncommon
Medication residue Very rare
Nausea Uncommon
Ocular discomfort Common
Ocular hyperaemia Common
Photophobia Uncommon
Skin Eruption Very rare
Stevens-Johnson syndrome Very rare
Urticaria Very rare
Vision blurred Very rare
Visual acuity reduced Very rare

Different Units By MoH Code

Nafloxin Cooper  MoH 2060705 :
Form Eye drops, solution
Packaging Bottle
Package Size 5ml
Strength 3mg/ml
Storage Condition 2-30°C protect from light
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 03/06/2017
Rejection Year 12/02/2019
Rejection Reason Incomplete study


Price Comparison

● Country: Greece
● Package Size: 5ml
● Public Price: 2.7 EUR ( 261,565.20 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,027 EUR ( 0.00 LBP )
● Exfactory Price: 1.87 EUR
● Pharmacy Price: 1.96 EUR ( 189876.96 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info